GlassScriptPhysician profile
Kendyl Sumner
NPI 1073275335
$1,672.77
in general payments reported to CMS, 2019-2025
15 companies · $759 in 2025
The $759 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.63 · 2022: $506 · 2023: $218 · 2024: $140 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.08 |
| Education | $115.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $513.01 | 2024-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $300.52 | 2022-2023 | Relistor |
| Protega Pharmaceutials INC | $147.03 | 2022-2023 | Roxybond |
| Spirair, INC. | $126.59 | 2025 | |
| Glaxosmithkline, LLC. | $114.06 | 2025 | Nucala |
| Genzyme Corporation | $113.92 | 2025 | |
| Ibsa Pharma INC. | $95.41 | 2021-2023 | Tirosint, Licart |
| Nevro Corp. | $57.51 | 2021-2022 | |
| Abbvie INC. | $44.36 | 2022 | |
| Scilex Pharmaceuticals INC. | $39.50 | 2022-2023 | Ztlido |
| Inspire Medical Systems, INC. | $31.67 | 2025 | Inspire |
| Hikma Pharmaceuticals USA | $29.58 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.71 | 2022 | |
| Bioventus LLC | $21.30 | 2022 | |
| Amgen INC. | $16.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendyl Sumner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.